November 25, 2014
The University of Texas Medical Branch is part of a collaboration led by the Oak Crest Institute of Science that received a $20 million grant from the National Institutes of Health to develop a novel intravaginal ring capable of delivering powerful antiretroviral drugs to prevent the spread of sexually transmitted HIV in women. The total award to UTMB is approximately $2.5 million.
After more than 40 years of research, prevention of HIV infection continues to be a critical global health priority. The World Health Organization reports that there are approximately 35 million people currently living with HIV, with about 70 percent from Sub-Saharan Africa.
Intravaginal rings, available commercially for contraception and hormone replacement therapy, show promise as a drug delivery system to prevent HIV infection, but most prototypes can’t deliver multiple-drug combinations of the many available HIV antiretroviral drugs. While combinations of three antiretroviral drugs are highly... more »
November 19, 2014
It’s known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What’s less known is that cholesterol levels... more »